ASMB GILEAD SCIENCES INC. buys $0 worth of shares
Oct 04, 2025, 4:35 AM
10.39%
What does ASMB do
Assembly Biosciences, a biotechnology company based in South San Francisco, develops treatments for chronic hepatitis B and other infectious diseases, with a pipeline including multiple antiviral agents. The company, which went public in December 2010, employs 65 people.
GILEAD SCIENCES INC. bought 4,591,840 shares of ASMB on 8 August at $0.00 per share, worth a total of $0. They now own 4,505,391 ASMB shares, or a 5312% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.